| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs JS Smolen, R Landewé, FC Breedveld, M Dougados, P Emery, ... Annals of the rheumatic diseases 69 (6), 964-975, 2010 | 2392 | 2010 |
| Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community C Vitali, S Bombardieri, HM Moutsopoulos, G Balestrieri, W Bencivelli, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1993 | 1887 | 1993 |
| EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases S Van Assen, N Agmon-Levin, O Elkayam, R Cervera, MF Doran, ... Annals of the rheumatic diseases 70 (3), 414-422, 2011 | 777 | 2011 |
| Anti-inflammatory and immunosuppressive drugs and reproduction M Østensen, M Khamashta, M Lockshin, A Parke, A Brucato, H Carp, ... Arthritis research & therapy 8, 1-19, 2006 | 680 | 2006 |
| European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies L Gossec, JS Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, ... Annals of the rheumatic diseases 71 (1), 4-12, 2012 | 607 | 2012 |
| Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR … JL Nam, KL Winthrop, RF van Vollenhoven, K Pavelka, G Valesini, ... Annals of the Rheumatic Diseases 69 (6), 976-986, 2010 | 558 | 2010 |
| Inflammation as “common soil” of the multifactorial diseases R Scrivo, M Vasile, I Bartosiewicz, G Valesini Autoimmunity reviews 10 (7), 369-374, 2011 | 373 | 2011 |
| The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome O Amengual, T Atsumi, MA Khamashta, GRV Hughes Thrombosis and haemostasis 79 (02), 276-281, 1998 | 348 | 1998 |
| Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI) R Seror, E Theander, JG Brun, M Ramos-Casals, V Valim, T Dörner, ... Annals of the rheumatic diseases 74 (5), 859-866, 2015 | 309 | 2015 |
| Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid‐like structures in Sjögren's syndrome F Barone, M Bombardieri, A Manzo, MC Blades, PR Morgan, ... Arthritis & Rheumatism 52 (6), 1773-1784, 2005 | 308 | 2005 |
| Citrullination and autoimmunity G Valesini, MC Gerardi, C Iannuccelli, VA Pacucci, M Pendolino, ... Mosaic of Autoimmunity, 117-126, 2019 | 301 | 2019 |
| Primary Sjögren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients C Baldini, P Pepe, L Quartuccio, R Priori, E Bartoloni, A Alunno, ... Rheumatology 53 (5), 839-844, 2014 | 297 | 2014 |
| Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical … C Alessandri, M Bombardieri, N Papa, M Cinquini, L Magrini, A Tincani, ... Annals of the rheumatic diseases 63 (10), 1218-1221, 2004 | 287 | 2004 |
| Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo C Ferri, V Pittoni, A Piccoli, O Laurenti, MR Cassone, C Bellini, G Properzi, ... The Journal of Clinical Endocrinology & Metabolism 80 (3), 829-835, 1995 | 275 | 1995 |
| Anti–β2‐glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts M Sorice, A Longo, A Capozzi, T Garofalo, R Misasi, C Alessandri, F Conti, ... Arthritis & Rheumatism 56 (8), 2687-2697, 2007 | 249 | 2007 |
| Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis … M Bombardieri, F Barone, F Humby, S Kelly, M McGurk, P Morgan, ... The Journal of Immunology 179 (7), 4929-4938, 2007 | 248 | 2007 |
| Smoke and autoimmunity: The fire behind the disease C Perricone, M Versini, D Ben-Ami, S Gertel, A Watad, MJ Segel, ... Autoimmunity reviews 15 (4), 354-374, 2016 | 239 | 2016 |
| Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived … C Vitali, G Palombi, C Baldini, M Benucci, S Bombardieri, M Covelli, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 235 | 2007 |
| Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs M Østensen, M Lockshin, A Doria, G Valesini, P Meroni, C Gordon, ... Rheumatology 47 (suppl_3), iii28-iii31, 2008 | 234 | 2008 |
| Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double‐blind, placebo‐controlled trials MEB Clowse, DJ Wallace, RA Furie, MA Petri, MC Pike, P Leszczyński, ... Arthritis & rheumatology 69 (2), 362-375, 2017 | 231 | 2017 |
